Refractory Gastrointestinal Tract Tumors- EPON-PRIME
People with Advanced, Refractory Gastrointestinal Tract Tumors are asked to participate in a research study being conducted by Montefiore Medical Center.
You may be eligible to participate in this study if you:
- Are a male or female at least 18 years of age
- Have advanced, metastatic or unresectable GI tract tumors that are refractory or intolerant to existing available therapies
- Have adequate bone marrow, liver, and renal function
- Have not received treatment with IV 5-FU or oral 5-FU analogs in the 4 weeks
- Hepatitis C or B infection and received antiviral treatment, has a negative viral load at Screening
- The HIV infection, it is controlled with undetectable viral load with antiretroviral treatment
You may NOT participate in this study if you:
- Have current brain metastasis
- Have other clinically significant cardiac disease
- Have had major surgery, open biopsy, or significant traumatic injury within 4 weeks
- Have other primary cancer requiring treatment within the last 3 years
- Have congenital long QT syndrome or a family history of long QT syndrome
- Have a history or presence of clinically significant abnormal 12-lead ECG
- Are pregnant or lactating
Contact Information
Mohammad Ghalib, Study Coordinator
1695 Eastchester Road, 2nd Floor
Bronx, New York 10461
Phone: (718) 405-8515
Email: mhghalib@montefiore.org